COMMUNIQUÉS West-GlobeNewswire
-
Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019
12/02/2019 - 14:30 -
Genocea Announces Private Placement Financing of Up to $39 Million
12/02/2019 - 14:30 -
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update
12/02/2019 - 14:30 -
Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.
12/02/2019 - 14:14 -
Medexus Lists October 2018 Unsecured Convertible Debentures on the TSX Venture Exchange
12/02/2019 - 14:00 -
WW Schedules Fourth Quarter and Full Year 2018 Earnings Conference Call
12/02/2019 - 14:00 -
IRIDEX Announces Resolution of its Dispute with Quantel Medical
12/02/2019 - 14:00 -
Progressive Care Inc. Announces CEO, Shital Mars as Keynote Speaker at Cold Chain Global Forum in Toronto, Canada
12/02/2019 - 14:00 -
BioSig Technologies Inc. Issues 2019 Shareholder Letter
12/02/2019 - 13:52 -
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors
12/02/2019 - 13:38 -
Loop Industries Completes and Expands Supply Agreement With Danone for 100% Sustainable PET
12/02/2019 - 13:30 -
Spark Therapeutics to Host Conference Call on Tuesday, Feb. 19 at 8:30 a.m. ET to Discuss 2018 Results and Recent Business Highlights
12/02/2019 - 13:30 -
Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan in Patients with Decompensated NASH Cirrhosis
12/02/2019 - 13:30 -
Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
12/02/2019 - 13:30 -
Parkinson’s Disease: ProMIS Neurosciences Identifies Several Antibody Drug Candidates Showing Best-in-Class Selectivity for Toxic Forms of Alpha-Synuclein Compared to other Therapeutic Antibodies in Development
12/02/2019 - 13:30 -
Canada House Wellness Group Inc. Announces Full Operations in its Facility, Commences Full-Scale Production of EU-GMP Certified Cannabis
12/02/2019 - 13:00 -
Microbix Reports Results for Q1 Fiscal 2019
12/02/2019 - 13:00 -
Yuhan Corp and Sorrento Therapeutics Announce Closing of a $40m USD Financing for Joint Venture ImmuneOncia to Support Advancement of Immuno-Oncology Program
12/02/2019 - 13:00 -
Verrica Announces Late-Breaking Oral Presentation at the 2019 American Academy of Dermatology Annual Meeting
12/02/2019 - 13:00
Pages